Press Release

PhRMA Statement on the Nomination of Dr. Robert Califf to Lead the U.S. Food and Drug Administration

WASHINGTON, D.C. (November 12, 2021) – Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Stephen J. Ubl issued the following statement today on the nomination of Dr. Robert Califf to lead the U.S. Food and Drug Administration (FDA):

“Congratulations to Dr. Robert Califf for being nominated as the next commissioner of the U.S. Food and Drug Administration. It’s vital that we have a commissioner who understands the important role the FDA plays in promoting public health and providing science-based oversight of our nation’s medicine supply. We hope the confirmation process will proceed quickly, and we look forward to continuing to work with the FDA as we fight the pandemic and other deadly diseases.”


About PhRMA

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. Since 2000, PhRMA member companies have invested more than $1 trillion in the search for new treatments and cures, including $91.1 billion in 2020 alone.

Connect with PhRMA

For information on how innovative medicines save lives, please visit:

www.PhRMA.org 
www.Innovation.org 
www.MAT.org
www.Facebook.com/PhRMA 
www.Twitter.com/PhRMA